Durvalumab after chemoradiotherapy in stage III NSCLC: 4-year survival update from the phase III PACIFIC trial

---

Faivre-Finn C., Vicente D., Kurata T., Planchard D., Paz-Ares L., Vansteenkiste J. F., ...More

ESMO Virtual Congress, ELECTR NETWORK, 19 September - 18 October 2020, vol.31

• Publication Type: Conference Paper / Summary Text
• Volume: 31
• Doi Number: 10.1016/j.annonc.2020.08.2281
• Country: ELECTR NETWORK
• Istanbul University Affiliated: No